首页 › 基金 › MONTANOVA CAPITAL, LLC › RCUS
MONTANOVA CAPITAL, LLC 对 RCUS 的持仓历史
ARCUS BIOSCIENCES INC · 医疗保健
MONTANOVA CAPITAL, LLC 在 Q2 2026 的 13F 申报中披露持有 RCUS(ARCUS BIOSCIENCES INC)4,776,423 股,市值约 US$147.3M,约占其申报组合的 2.69%,在其申报持仓中市值排名第 10 位。 MONTANOVA CAPITAL, LLC 最近 12 个申报季度中有 12 个季度披露了 RCUS 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
MONTANOVA CAPITAL, LLC 对 RCUS 的持仓演变
MONTANOVA CAPITAL, LLC 于 Q3 2023 首次披露 RCUS 持仓:597,099 股(约 US$10.7M)。 该持仓在 Q2 2026 达到峰值 4,776,423 股,市值约 US$147.3M。 在 12 次申报中,MONTANOVA CAPITAL, LLC 4 次增持、4 次减持、3 次保持不变。 最近一期申报(Q2 2026)显示持股 4,776,423 股、市值约 US$147.3M,环比减持 -254,570 股。。 持仓曾出现大幅变动:Q4 2023 增持约 60% (随后一个季度股价下跌 1%)、Q1 2025 增持约 344% (随后一个季度股价上涨 4%)、Q2 2025 增持约 44% (随后一个季度股价上涨 67%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 597.10K | $10.72M | 新进 |
| Q4 2023 | 957.30K | $18.28M | 增持 |
| Q1 2024 | 957.30K | $18.07M | 持有 |
| Q2 2024 | 957.30K | $14.58M | 持有 |
| Q3 2024 | 663.60K | $10.15M | 减持 |
| Q4 2024 | 576.16K | $8.58M | 减持 |
| Q1 2025 | 2.56M | $20.10M | 增持 |
| Q2 2025 | 3.69M | $30.03M | 增持 |
| Q3 2025 | 3.69M | $50.17M | 持有 |
| Q4 2025 | 5.19M | $123.65M | 增持 |
| Q1 2026 | 5.03M | $108.67M | 减持 |
| Q2 2026 | 4.78M | $147.26M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RCUS 与 13F 数据
RCUS(ARCUS BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 RCUS,申报仓位最大的包括:GILEAD SCIENCES, INC. (US$968.8M), Siren, L.L.C. (US$74.6M), SAMLYN CAPITAL, LLC (US$47.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RCUS 的基金
- GILEAD SCIENCES, INC. 31.42M 股 · $968.83M · Q2 2026
- Siren, L.L.C. 2.42M 股 · $74.62M · Q2 2026
- SAMLYN CAPITAL, LLC 1.55M 股 · $47.70M · Q2 2026
- Soleus Capital Management, L.P. 1.17M 股 · $36.03M · Q2 2026
- Sofinnova Investments, Inc. 945.69K 股 · $29.16M · Q2 2026
- Parkman Healthcare Partners LLC 919.27K 股 · $28.34M · Q2 2026
- BAKER BROS. ADVISORS LP 844.82K 股 · $26.05M · Q2 2026
- Logos Global Management LP 650.00K 股 · $20.04M · Q2 2026
- Ikarian Capital, LLC 504.56K 股 · $15.56M · Q2 2026
- Decheng Capital LLC 464.78K 股 · $14.33M · Q2 2026
- DAFNA Capital Management LLC 441.83K 股 · $13.62M · Q2 2026
- Patient Square Capital LP 355.80K 股 · $10.97M · Q2 2026
更多关于 MONTANOVA CAPITAL, LLC
常见问题
How long has MONTANOVA CAPITAL, LLC held RCUS?
MONTANOVA CAPITAL, LLC has disclosed RCUS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is MONTANOVA CAPITAL, LLC's current position in RCUS?
As of Q2 2026, MONTANOVA CAPITAL, LLC holds 4.78M shares of RCUS (ARCUS BIOSCIENCES INC), valued at $147.26M, representing 2.69% of its reported portfolio and ranking #10.
Has MONTANOVA CAPITAL, LLC been buying or selling RCUS?
In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC reduced its position in RCUS. The position peaked in Q2 2026 at 4.78M shares.
Which other funds hold RCUS?
Other major institutional holders of RCUS include GILEAD SCIENCES, INC., Siren, L.L.C., SAMLYN CAPITAL, LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.